Detailed information for compound 170899

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 373.357 | Formula: C19H19NO7
  • H donors: 1 H acceptors: 2 LogP: 2.63 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cc(cc(c1OC)OC)n1c(=O)occ1c1ccc(c(c1)O)OC
  • InChi: 1S/C19H19NO7/c1-23-15-6-5-11(7-14(15)21)13-10-27-19(22)20(13)12-8-16(24-2)18(26-4)17(9-12)25-3/h5-10,21H,1-4H3
  • InChiKey: KWYRQMYACXXRMI-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

No curated genes were found associated with this compound

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
No druggable targets predicted by sequence similarity

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Onchocerca volvulus 0.0053 0 0.5
Entamoeba histolytica cysteine protease, putative 0.0053 0 0.5
Echinococcus granulosus cathepsin b 0.0287 1 1
Onchocerca volvulus Cathepsin F homolog 0.0053 0 0.5
Plasmodium vivax vivapain-2 0.0053 0 0.5
Entamoeba histolytica cysteine proteinase, putative 0.0053 0 0.5
Plasmodium falciparum cysteine proteinase falcipain 2a 0.0053 0 0.5
Schistosoma mansoni cathepsin B-like peptidase (C01 family) 0.0103 0.2134 0.2134
Onchocerca volvulus 0.0053 0 0.5
Echinococcus multilocularis cathepsin b 0.0287 1 1
Onchocerca volvulus Cathepsin L homolog 0.0053 0 0.5
Toxoplasma gondii cathepsin B 0.0103 0.2134 1
Trypanosoma brucei cysteine peptidase C (CPC) 0.0103 0.2134 1
Trichomonas vaginalis Clan CA, family C1, cathepsin B-like cysteine peptidase 0.0103 0.2134 1
Plasmodium falciparum cysteine proteinase falcipain 2b 0.0053 0 0.5
Trypanosoma cruzi cysteine peptidase C (CPC), putative 0.0103 0.2134 0.2134
Leishmania major cysteine peptidase C (CPC),CPC cysteine peptidase, Clan CA, family C1, Cathepsin B-like 0.0103 0.2134 1
Onchocerca volvulus 0.0053 0 0.5
Onchocerca volvulus Cathepsin L homolog 0.0053 0 0.5
Entamoeba histolytica cysteine proteinase, putative 0.0053 0 0.5
Giardia lamblia Cathepsin B precursor 0.0103 0.2134 0.5
Entamoeba histolytica cysteine proteinase, putative 0.0053 0 0.5
Giardia lamblia Cathepsin B precursor 0.0103 0.2134 0.5
Schistosoma mansoni cathepsin B-like peptidase (C01 family) 0.0287 1 1
Schistosoma mansoni cathepsin B-like peptidase (C01 family) 0.0287 1 1
Schistosoma mansoni SmCB2 peptidase (C01 family) 0.0287 1 1
Echinococcus multilocularis cathepsin b 0.0287 1 1
Loa Loa (eye worm) hypothetical protein 0.0287 1 1
Plasmodium falciparum cysteine proteinase falcipain 3 0.0053 0 0.5
Giardia lamblia Cathepsin B precursor 0.0103 0.2134 0.5
Echinococcus granulosus cathepsin b 0.0287 1 1
Onchocerca volvulus 0.0053 0 0.5
Trypanosoma cruzi cysteine peptidase C (CPC), putative 0.0287 1 1
Onchocerca volvulus 0.0053 0 0.5
Schistosoma mansoni cathepsin B-like peptidase (C01 family) 0.0287 1 1
Onchocerca volvulus 0.0053 0 0.5
Loa Loa (eye worm) cathepsin B 0.0103 0.2134 0.2134
Onchocerca volvulus 0.0053 0 0.5
Onchocerca volvulus 0.0053 0 0.5
Plasmodium vivax vivapain-2 0.0053 0 0.5

Activities

Activity type Activity value Assay description Source Reference
IC50 (functional) = 0.9 nM Concentration of the compound which produces 50% inhibition of growth of murine melanoma B16 cell line ChEMBL. 11714613
IC50 (functional) = 0.9 nM Concentration of the compound which produces 50% inhibition of growth of murine melanoma B16 cell line ChEMBL. 11714613
IC50 (functional) = 1.7 nM Concentration of the compound which produces 50% inhibition of growth of human colon tumor HCT 116 ChEMBL. 11714613
IC50 (functional) = 1.7 nM Concentration of the compound which produces 50% inhibition of growth of human colon tumor HCT 116 ChEMBL. 11714613
IC50 (functional) = 2.3 nM Concentration of the compound which produces 50% inhibition of growth of prostrate tumor cell line PC-3 ChEMBL. 11714613
IC50 (functional) = 2.3 nM Concentration of the compound which produces 50% inhibition of growth of prostrate tumor cell line PC-3 ChEMBL. 11714613
IC50 (functional) = 2.9 nM Concentration of the compound which produces 50% inhibition of growth of human breast tumor MCF-7 cell line ChEMBL. 11714613
IC50 (functional) = 2.9 nM Concentration of the compound which produces 50% inhibition of growth of human breast tumor MCF-7 cell line ChEMBL. 11714613
IC50 (functional) = 3.1 nM Concentration of the compound which produces 50% inhibition of growth of human lung carcinoma cell line A549 ChEMBL. 11714613
IC50 (functional) = 3.1 nM Concentration of the compound which produces 50% inhibition of growth of human lung carcinoma cell line A549 ChEMBL. 11714613

Phenotypes

Whole-cell/tissue/organism interactions

Species name Source Reference Is orphan
Mus musculus ChEMBL23 11714613
Homo sapiens ChEMBL23 11714613

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

No external resources registered for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.